why choose us

First received: June 02, 2023

Clinical Trial: Immunogenicity and Safety Study of SARS-CoV-2 DNA Vaccine (ICCOV)

Study Status: Completed

Recruit Status: RECRUITING

Condition: COVID-19

Study Type: INTERVENTIONAL


Official Title: An Open-label and Single-center Phase IIa Trial to Evaluate the Immunogenicity and Safety of SARS-CoV-2 DNA Vaccine (ICCOV) in Healthy Subjects Aged 18-75 Years

Brief Summary: This is an open-labeled, no placebo, Phase IIa clinical trial.The purpose of this study is to evaluate the immunogenicity and safety of one booster vaccine dose of SARS-CoV-2 DNA Vaccine (ICCOV) in adults aged 18 to 75 years who have received two to four dosese of COVID-19 vaccine.

Read more